T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.08T
| $9.95B | 2.11% |
377,660,989
-2,700,695
| -0.7% | -$72.5M |
|
2
Amazon
AMZN
$2.53T
| $7.12B | 1.51% |
459,021,800
+6,904,560
| +2% | +$108M |
|
3
Danaher
DHR
$138B
| $6.52B | 1.38% |
113,200,848
+6,257,070
| +6% | +$339M |
|
4
Visa
V
$673B
| $6.52B | 1.38% |
99,464,036
-7,714,296
| -7% | -$464M |
|
5
Booking.com
BKNG
$150B
| $5.76B | 1.22% |
126,235,925
+5,019,950
| +4% | +$227M |
|
6
Apple
AAPL
$4.9T
| $5.19B | 1.1% |
188,219,816
+7,718,732
| +4% | +$210M |
|
7
Boeing
BA
$175B
| $5.09B | 1.08% |
39,127,112
+338,010
| +0.9% | +$42.9M |
|
|
8
Gilead Sciences
GILD
$163B
| $4.86B | 1.03% |
51,601,518
-7,311,805
| -12% | -$756M |
|
9
American Airlines Group
AAL
$10.2B
| $4.84B | 1.03% |
90,167,041
+2,078,233
| +2% | +$89.5M |
|
10
McKesson
MCK
$101B
| $4.7B | 1% |
22,659,667
-96,743
| -0.4% | -$19.7M |
|
11
Baidu
BIDU
$36.5B
| $4.45B | 0.95% |
19,537,013
-189,659
| -1% | -$43.5M |
|
12
Meta Platforms (Facebook)
META
$1.37T
| $4.36B | 0.93% |
55,899,033
+6,821,300
| +14% | +$521M |
|
13
Biogen
BIIB
$30.7B
| $4.13B | 0.88% |
12,176,548
-614,504
| -5% | -$199M |
|
14
JPMorgan Chase
JPM
$933B
| $3.99B | 0.85% |
63,754,188
-3,911,552
| -6% | -$235M |
|
|
AGN
15
DELISTED
Allergan Inc
AGN
| $3.89B | 0.83% |
18,285,285
+68,276
| +0.4% | +$13.6M |
|
16
Lowe's Companies
LOW
$118B
| $3.85B | 0.82% |
56,018,206
-2,670,029
| -5% | -$160M |
|
17
GE Aerospace
GE
$368B
| $3.74B | 0.79% |
30,896,545
+1,549,328
| +5% | +$191M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.73B | 0.79% |
20,175,391
+466,737
| +2% | +$86.5M |
|
19
Morgan Stanley
MS
$330B
| $3.35B | 0.71% |
86,373,996
+3,455,244
| +4% | +$123M |
|
20
Intuitive Surgical
ISRG
$126B
| $3.04B | 0.65% |
51,711,300
+946,008
| +2% | +$52.7M |
|
21
UnitedHealth
UNH
$383B
| $3.03B | 0.64% |
29,957,618
-4,808,043
| -14% | -$456M |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $3.02B | 0.64% |
27,024,477
-188,386
| -0.7% | -$19.9M |
|
23
Mastercard
MA
$510B
| $2.99B | 0.63% |
34,706,368
-2,335,827
| -6% | -$191M |
|
24
Thermo Fisher Scientific
TMO
$214B
| $2.92B | 0.62% |
23,327,070
+1,061,187
| +5% | +$129M |
|
|
PCP
25
DELISTED
PRECISION CASTPARTS CORP
PCP
| $2.87B | 0.61% |
11,897,706
-277,956
| -2% | -$64.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.